Literature DB >> 8426468

Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations.

J L Huret1, A Brizard, R Slater, C Charrin, M F Bertheas, F Guilhot, K Hählen, W Kroes, E van Leeuwen, E V Schoot.   

Abstract

We report on 16 cases of t(11;19) acute leukemia and review data of published observations: altogether updated data of 48 patients are analyzed. Four hematological groups could be distinguished: (i) 13 cases of acute lymphoblastic leukemia (ALL) of B lineage, mostly CD19+; (ii) eight cases of biphenotypic leukemia: CD19+ (most often) ALL but with simultaneous or inducible expression of differentiation marker of monocytic lineage. The B lineage and biphenotypic leukemias were predominantly found in female infants; (iii) four cases of T-ALL in children; and (iv) 23 acute non-lymphocytic leukemia (ANLL) cases generally of M4 or M5 subtype, predominantly in males. Cytogenetically, at least two subtypes were observed with possibly an identical breakpoint on 11q23 but discrete breakpoints on 19p: lymphoid, biphenotypic, and most congenital myeloid cases showed a distal breakpoint on 19p13 producing 11q- and 19p+ derivatives, while most older myeloid cases showed 11q+ and 19p- derivatives as a result of a more proximal breakpoint on 19p12 or p13.1. The latter type was clearly detected using R bands but barely visible using Q or G bands while the other translocation was easy to detect with G bands but could be missed with R bands. The white blood cell count is usually high in these t(11;19) acute leukemias and prognosis is poor, except for T-ALL cases.

Entities:  

Mesh:

Year:  1993        PMID: 8426468

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  11 in total

Review 1.  Biology and treatment of adult acute lymphoblastic leukemia.

Authors:  L Levitt; R Lin
Journal:  West J Med       Date:  1996-02

2.  Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.

Authors:  C Lavau; R T Luo; C Du; M J Thirman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 3.  ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia.

Authors:  Jianbiao Zhou; Yvonne Ng; Wee-Joo Chng
Journal:  Cell Mol Life Sci       Date:  2018-07-31       Impact factor: 9.261

4.  A case of therapy-related acute lymphoblastic leukemia with t(11;19)(q23;p13.3) and MLL/MLLT1 gene rearrangement.

Authors:  Byong-Joon Yoo; Myung-Hyun Nam; Hwa-Jung Sung; Chae-Seung Lim; Chang-Kyu Lee; Yun-Jung Cho; Kap-No Lee; Soo-Young Yoon
Journal:  Korean J Lab Med       Date:  2011-01

5.  Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.

Authors:  K L Guan; C W Jenkins; Y Li; C L O'Keefe; S Noh; X Wu; M Zariwala; A G Matera; Y Xiong
Journal:  Mol Biol Cell       Date:  1996-01       Impact factor: 4.138

6.  Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.

Authors:  Xiaoli Mi; Gabriel Griffin; Winston Lee; Sanjay Patel; Robert Ohgami; Chi Young Ok; Sa Wang; Julia T Geyer; Wenbin Xiao; Mikhail Roshal; Jacqueline S Garcia; Lewis B Silverman; Stephen E Sallan; Jon C Aster; Marian H Harris; Olga K Weinberg
Journal:  Am J Hematol       Date:  2018-09-26       Impact factor: 10.047

7.  Developmentally induced Mll1 loss reveals defects in postnatal haematopoiesis.

Authors:  T Gan; C D Jude; K Zaffuto; P Ernst
Journal:  Leukemia       Date:  2010-08-19       Impact factor: 11.528

8.  Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.

Authors:  M J Thirman; D A Levitan; H Kobayashi; M C Simon; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 9.  Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future management.

Authors:  Maurie Markman
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

10.  Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3).

Authors:  B Bhatnagar; J S Blachly; J Kohlschmidt; A-K Eisfeld; S Volinia; D Nicolet; A J Carroll; A W Block; J E Kolitz; R M Stone; K Mrózek; J C Byrd; C D Bloomfield
Journal:  Leukemia       Date:  2015-12-16       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.